Abstract
Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effective drugs or dosing regimens are limited. To better identify treatment approaches and associated toxicities, we collected a series of case reports from the Emerging Infections Network. Side effects were common and often led to changing or discontinuing therapy.
Keywords:
Mycobacterium abscessus; Nontuberculous mycobacteria; adverse effects; bacteria; therapeutics; treatment; tuberculosis and other mycobacteria.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adult
-
Aged
-
Anti-Infective Agents / administration & dosage
-
Anti-Infective Agents / adverse effects
-
Anti-Infective Agents / therapeutic use
-
Drug Therapy, Combination
-
Female
-
Humans
-
Male
-
Middle Aged
-
Mycobacterium Infections, Nontuberculous / drug therapy*
-
Mycobacterium Infections, Nontuberculous / epidemiology
-
Mycobacterium Infections, Nontuberculous / microbiology*
-
Nontuberculous Mycobacteria / drug effects*
-
Treatment Outcome